The 21st Century Cures Act: FDA Implementation One Year Later: Some Action, Some Results, Some Questions
- PMID: 29491696
- PMCID: PMC5821241
The 21st Century Cures Act: FDA Implementation One Year Later: Some Action, Some Results, Some Questions
Abstract
The Food and Drug Administration has made significant progress implementing some of the 60 provisions of the 21st Century Cures Act passed in 2016. The author discusses the successes and shortcomings of the agency's regulatory activities.
References
-
- Mallinckrodt Pharmaceuticals. U.S. FDA designates Mallinckrodt’s StrataGraft as regenerative medicine advanced therapy. Jul 18, 2017. [Accessed January 16, 2018]. Available at: www.mallinckrodt.com/about/news-and-media/2286957.
-
- Upton F.H.R. 6—21st Century Cures Act. 114th Congress (2015–2016) Jul 13, 2015. [Accessed January 16, 2018]. Available at: www.congress.gov/bill/114th-congress/house-bill/6/text.
-
- Committee on Energy and Commerce Subcommittee on Health. Implementing the 21st Century Cures Act: An update from FDA and NIH. Nov 30, 2017. [Accessed January 16, 2018]. Available at: https://energycommerce.house.gov/hearings/implementing-21st-century-cure....
-
- Food and Drug Administration. Transcript: meeting of the Science Board to the FDA. May 9, 2017. [Accessed January 16, 2018]. Available at: www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Scie....
-
- Food and Drug Administration. Information Exchange and Data Transformation (INFORMED) May 10, 2017. [Accessed January 17, 2018]. Available at: www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/OC....
LinkOut - more resources
Full Text Sources